Search results
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 2 days agoThe bulk of long COVID research carried out over the past four years has attempted to understand the...
Man’s COVID Infection Lasted Nearly 2 Years, Long Enough To Evolve A New Variant
IFLScience· 5 days agoThe unfortunate case of a man in The Netherlands who was infected with COVID-19 for more than a year...
‘Longest-suffering’ Covid patient, 72, dies after infection lasted for 613 DAYS
The US Sun· 6 days agoA MAN in Amsterdam has died after suffering from Covid continuously for a record-breaking 613 days....
COVID-19 booster immunity lasts much longer than primary series alone, study shows
Medical Xpress· 6 days agoThe study used Canadian vaccine data collected from individuals living in long-term care, as well as frontline health-care workers working in long-term ...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 8 hours agoThe pharmaceutical company's EPS Rating, a measure of profitability, is 35 out of a best-possible...
More cows are being tested and tracked for bird flu. Here's what that means
WFMJ Youngstown· 1 hour agoU.S. health and agriculture officials are ramping up testing and tracking of bird flu in dairy cows...
Hay fever symptoms, causes, treatments and cures
The Telegraph via Yahoo News· 19 hours agoMost of us are delighted when spring finally arrives, but for millions of hay fever sufferers, the warmer temperatures and longer days signal the start...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 3 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
Danaher (DHR) Gears Up to Post Q1 Earnings: Is a Beat Likely?
Zacks via Yahoo Finance· 6 days agoDanaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 7 days agoQuebec's INESSS recommends BEYFORTUS® for the prevention of RSV for all infants 8 months of age and younger(1) Canada NewsWire TORONTO, April 18, 2024 BEYFORTUS® (nirsevimab) is the first < ...
